T. Rowe Price Investment Management, Inc. Immatics N.V. Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immatics N.V. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 6,304,672 shares of IMTX stock, worth $73.3 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,304,672
Previous 2,824,169
123.24%
Holding current value
$73.3 Million
Previous $29.7 Million
122.82%
% of portfolio
0.04%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding IMTX
# of Institutions
85Shares Held
68.8MCall Options Held
507KPut Options Held
170K-
Rtw Investments, LP New York, NY10MShares$116 Million1.69% of portfolio
-
Wellington Management Group LLP Boston, MA8.33MShares$96.8 Million0.02% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$74.9 Million0.86% of portfolio
-
Perceptive Advisors LLC New York, NY4.58MShares$53.2 Million1.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.23MShares$37.5 Million0.0% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $886M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...